Showing results (11-20 of 4,900) with videos related to
Sort By:
Pageof 490
Current Opinion in Rheumatology|October 18, 2001
Regulation of CD40 ligand expression in systemic lupus erythematosusM K Crow, K A KirouThe Journal of Clinical Investigation|August 1, 1996
Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytesM Koshy, D Berger, M K CrowBiotechniques|March 10, 2001
Protein aggregation mediated by cysteine oxidation during the stacking phase of discontinuous buffer SDS-PAGEM K Crow, N Karasavvas, A H SarrisThe New England Journal of Medicine|June 27, 1985
Systemic lupus erythematosus with deficiency of the T4 epitope on T helper/inducer cellsW Stohl, M K Crow, H G KunkelThe New England Journal of Medicine|February 13, 1986
Evidence for a defect in "switch" T cells in patients with immunodeficiency and hyperimmunoglobulinemia ML Mayer, S P Kwan, C Thompson, et al.The Journal of Experimental Medicine|November 1, 1986
Direct T helper-B cell interactions induce an early B cell activation antigenM K Crow, J A Jover, S M FriedmanThe Journal of Clinical Investigation|November 1, 1989
Biochemical basis of synergy between antigen and T-helper (Th) cell-mediated activation of resting human B cellsE K Chartash, M K Crow, S M FriedmanRheumatic Diseases Clinics of North America|February 1, 1993
Microbial superantigens as etiopathogenic agents in autoimmunityS M Friedman, J R Tumang, M K CrowJournal of Immunology (Baltimore, Md. : 1950)|September 1, 1985
Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1R Schwab, M K Crow, C Russo, et al.Cellular Immunology|December 1, 1985
Anti-immunoglobulin stimulation of human B lymphocytes is inhibited by anti-class II major histocompatibility complex antibodiesV R Bonagura, N Agostino, M K Crow, et al.Pageof 490